Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry

201896 citationsJournal Articlehybrid Open Access

Authors

Isabell Witzel · Universität Hamburg

Elena Laakmann · Universität Hamburg

Rudolf Weide · Koblenz University of Applied Sciences

Tanja Neunhöffer · Helios Dr. Horst Schmidt Kliniken Wiesbaden

TW Park-Simon · Medizinische Hochschule Hannover

Marcus Schmidt · Johannes Gutenberg University Mainz

Peter A. Fasching

Abstract

Prognosis of patients after developing BMs varies significantly according to the subtype. The outcome in this cohort is similarly poor in triple-negative and HR-positive/HER2-negative patients. Our results underline the high medical need for improvement of treatment and prevention strategies for BMs in breast cancer patients.

Topics & Keywords

Brain Metastases and Treatment Lung Cancer Research Studies Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Cancer

Volume 102, pp. 1-9

DOI: 10.1016/j.ejca.2018.07.004

Field-Weighted Citation Impact: 8.45